EGFR and glioblastoma: Glioblastoma, head and neck squamous cell carcinoma, esophagogastric adenocarcinoma and non-small cell lung cancer were the top four tumors with the highest alteration frequencies of LANCL2 and EGFR (Fig. 1A, B).